Abstract
Platelet-activating factor (PAF; 1–0-alkyl-2-acetyl-sn-3-phosphocholine) is a cell membrane metabolite generated in response to stimulation and, when released from the cell, becomes a potent cell activator. Tissue of the central nervous system is rich in phospholipid PAF precursors. PAF accumulates in brain following seizures and ischemia. Certain PAF antagonists prevent neural cell damage following ischemia, and other PAF antagonists suppress establishment of long-term potentiation. Several cultured neural cells synthesize PAF and retain it intracellularly. A potent PAF antagonist selective for a high-affinity, intracellular PAF binding site in brain suppresses stimulation of neural immediate-early gene expression in vitro and in in vitro. This effect suggests a role for PAF in long-term reparative processes that involve the stimulation of new protein synthesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham W, Dragunow M, Tate W (1992) The role of immediate-early genes in the stabilization of long-term potentiation. Mol Neurobiol 5:1–15
Arai A, Lynch G (1992) Antagonists of the platelet-activating factor receptor block long-term potentiation in hippocampal slices. Eur J Neurol 4:411–419
Bazan N (1970) Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218:1–10
Bazan N, Cluzel J (1992, in press) Membrane-derived lipid second messengers as targets for neuroprotection: Platelet-activating factor. In: Marangos P, Lai H (eds), Emerging Strategies in Neuroprotection, Boston, Birkhauser
Bazan N, Rodriguez de Turco E (1980) Membrane lipids in the pathogenesis of brain edema: Phospholipids and arachidonic acid, the earliest membrane components changed at the onset of ischemia. Adv Neurol 28:197–205
Bazan N, Birkle D, Tang W, Reddy T (1986) The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy. Adv Neurol 44:879–902
Bazan H, Braquet P, Reddy S, and Bazan N (1987a) Inhibition of the alkali burn-induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet-activating factor antagonist. J Ocul Pharmacol 3:357–362
Bazan H, Reddy S, Woodland J, Bazan N (1987b) The accumulation of platelet-activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Biochim Biophys Res Commun 149: 915–919
Bazan N, Squinto S, Braquet P, Panetta T, Marcheselli V (1991) Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a Fos/Jun/Ap-1 transcriptional signaling system. Lipids 26:1236–1242
Birkle D, Kurian P, Braquet P, Bazan NG (1988) The platelet-activating factor antagonist BN 52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J Neurochem 151:88–109
Blank M, Cress E, Wittle T, Snyder F (1981) In vivo metabolism of a new class of biologically active phospholipids: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet-activating, hypotensive phospholipid, Life Sci 29:769–775
Braquet P, Touqui L, Shen T, Vargaftig B (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39:97–145
Braquet P, Laurent J, Rolland A, Martin C., Pommier J, Hosford D, Esanu A (1990) From ginkgolides to N-substiuted piperidinothieno diazepines, a new series of highly potent PAF antagonists. Adv Prost Thromb Leuk Res 21:929–937
Bussolino F, Gremo F, Tetta C., Pescarmona G, Camussi G (1986) Production of platelet-activating factor by chick retina. J Biol Chem 261:16502–16508
Christy B, Nathans D (1989) DNA binding site of the growth-factor inducible protein Zif/268. Proc Natl Acad Sci USA 86:8737–8741
Christy B, Lau L, Nathans D (1988) A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with “zinc finger” sequences. Proc Natl Acad Sci USA 85:7857–7861
Clark G, Happel L, Zorumski C., Bazan N (1991) Platelet-activating factor augments excitatory synaptic neurotransmission in cultured rat hippocampal neurons. Soc Neurosci Abs 17:951
Cole A, Saffen D, Baraban J, Worley P (1989) Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340:474–476
del Cerro S, Arai A, Lynch G (1990) Inhibition of long-term potentiation by an antagonist of platelet-activating factor receptors. Behav Neural Biol 54:213–217
Dienel G (1984) Regional accumulation of calcium in post-ischemic brain. J Neurochem 43:913–917
Domingo M, Spinnewyn B, Charbrier P, Braquet P (1988) Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem Biophys Res Commun 151:730–736
Doucet J, Squinto S, Bazan NG (1990) Fos-Jun and the primary genomic response in the nervous system: Physiological role and possible pathophysiological significance. Mol Neurobiol 4:27–56
Francescangeli E, Goracci G (1989) The de novo synthesis of platelet-activating factor in rat brain. Biochem Biophys Res Commun 161: 107–112
Frerichs K, Lindsberg P, Hallenbeck J, Feurerstein G (1990) Platelet-activating factor and progressive brain damage following focal brain injury. J Neurosurg 73:223–233
Gilboe D, Kintner D, Fitzpatrick J, Emoto S, Esanu A, Braquet P, Bazan N (1991) Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonist. J Neurochem 56:311–319
Henson P (1987) Extracellular and intracellular activities of PAF. In: Snyder F (ed) Platelet-Activating Factor and Related Lipid Mediators, Plenum, New York, pp. 255–271
Herschman H (1991) Primary response genes induced by growth factors and tumor promoters. Ann Rev Biochem 60:281–319
Ho Y-S, Lee W, Snyderman R (1987) Chemoattractant-induced activation of c-fos gene expression in human monocytes. J Exp Med 165:1524–1538
Jörgenson M, Deckert J, Wright D, Gehlert D (1989) Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: An in situ hybridization study. Brain Res 484: 393–398
Junier M, Tiberghien C., Rougeot C., Fauer V, Dray F (1988) Inhibitory effect of PAF on lutenizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with characterization of specific PAF receptor sites. Endocrinology 123: 72–80
Kentroti S, Baker R, Lee K, Bruce C., Vernadakis A (1991) Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells. J Neurosci Res 28:497–506
Kindy M, Carney J, Dempsy R, Carney J (1991) Ischemic induction of protooncogene expression in gerbil brain. J Molec Neurosci 2:217–228
Kornecki E, Ehrlich Y (1988) Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 240:1792–1794
Koto K, Clark GD, Bazan N, Clifford D, Zormuski C Platelet-activating factor as a potential messenger in long-term potentiation, Soc Neurosci Abs 18 (in press)
Kumar R, Harvey S, Kester M, Hanahan D, Olson M (1988) Production and effects of platelet-activating factor in the rat brain. Biochim Biophys Acta 963:375–383
Linden D, Sheu F, Murakami K, Routtenberg A (1987) Enhancement of long-term potentiation by cis-unsaturated fatty acid. Relation to protein kinase C and phospholipase A2. J Neurosci 7:3783–3792
Lindsberg P, Yue T-L, Frerichs K, Hallenbeck J, Feuerstein G (1990) Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 21:1452–1457
Marcheselli VL, Bazan NG (1991) A specific antagonist for intracellular platelet-activating factor (PAF) binding sites lacks activity on synaptic membranes. Trans Amer Soc Neurochem 22:187
Marcheselli VL, Bazan NG (1992) ECS-induced zif-268 in hippocampus is inhibited by a PAF antagonist. Trans Amer Soc Neurochem 23
Marcheselli VL, Rossowska M, Domingo, MT, Braquet P, Bazan NG (1990) Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem 265: 9140–9145
Marcheselli VL, Doucet JP, Bazan NG (1991) Platelet-activating factor is a mediator of fos expression induced by a single seizure in rat hippocampus. Soc Neurosci Abs 17:349
Mazer B, Domenico J, Sawami H, Gelfand EW (1991) Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. J Immunol 146: 1914–1918
Morgan J, Curran T (1991) Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421–451
Morgan J, Cohen D, Hempstead J, Curran T (1987) Mapping patterns of c-fos in the nervous system. Science 237:192–197
Oberpichler H, Sauer D, Rosberg C., Mennel H, Krieglstein J (1990) PAF antagonist gingkolide-B reduces postischemic neuronal damage in the rat-brain hippocampus. J Cereb Blood Flow Metab 10:133–135
Onodera H, Kogure K, Ono Y, Igarashi K, Kiyota Y, Nagaoka A (1989) Proto-oncogene c-fos is transiently induced in the rat cerebral cortex after forebrain ischemia. Neurosci Lett 98:101–104
Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG (1987) Effects of a platelet-activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides, and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion-induced cerebral injury. Biochem Biophys Res Commun 149:580–587
Ransone L, Verma I (1990) Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6:539–557
Record M, Ribbes G, Terce F, Chap H (1989) Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism. J Cell Biochem 40:353–358
Rougeot C., Junier M, Minary P, Weidenfeld J, Braquet P, Dray F (1990) Intracerebroventricular injection of platelet-activating factor induces secretion of adrenocorticotropin, beta-endorphin and corticosterone in conscious rats--a possible link between the immune and nervous systems. Neuroendocrinology 51:315–319
Saffen D, Cole A, Worley P, Christy B, Ryder K, Baraban J (1988) Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc Natl Acad Sci 85:7795–7799
Sawyer D, Anderson O (1989) Platelet-activating factor is a general membrane perturbant. Biochim Biophys Acta 987:129–132
Schalasta G, Doppler C (1990) Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase C-type reactions. Mol Cell Biol 10:5558–5561
Schulman PG, Kuruvilla A, Putcha G, Mangus L, F-Johnson J, Shearer WT (1991) Platelet-activating factor induces phospholipid turnover calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line. J Immunol 146:1642–1647
Sheng M, Dougan S, McFadden G, Greenberg M (1988) Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 8:2782–2796
Sheng M, McFadden G, Greenberg M (1990) Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREEL Neuron 4:571–582
Shukla S (1992) Platelet-activating factor and signal transduction mechanisms. FASEB J 6:2296–2301
Siesjö B (1990) Calcium in the brain under physiological and pathological conditions. Eur Neurology 30:3–9
Siesjö BK, Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J Cereb Blood Flow Metab 9:127–140
Snyder F (1990) Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Amer J Physiol 259:C697–C708
Sogos V, Bussolino E, Pilia E, Torelli S, Gremo F (1990) Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture. J Neurosci Res 27:706–711
Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P (1987) Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins 34:337–349
Squinto SP, Block AL, Braquet P, Bazan NG (1989) Platelet-activating factor stimulates a Fos/Jun/AP-1 transcriptional signaling system in human neuroblastoma cells. J Neurosci Res 24:558–566
Squinto SP, Braquet P, Block A, Bazan NG (1990) Platelet-activating factor activated HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T-lymphocytes. J Mol Neurosci 2:79–85
Stewart A, Phillips W (1989) Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages. Br J Pharmacol 98:141–143
Stewart A, Dubbin P, Harris T, Dusting G (1989) Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells. Br J Pharmacol 96:503–505
Stewart A, Dubbin P, Harris T, Dusting G (1990) Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87:3215–3222
Sukhatme V, Cao X, Chang L, Tsai-Morris C., Stamenkovich D, Ferreira P, Cohen D, Edwards S, Shows T, Curran T, Le Beau M, Adamson E (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37–43
Tripathi Y, Kandala J, Guntaka R, Lim R, Shukla S (1991) Platelet-activating factor induces expression of early response genes c-fos and tis-1 in human epidermoid carcinoma cells. Life Sci 49:1761–1767
Vallari D, Record M, Snyder F (1990) Conversion of alkylacetyl glycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator. Arch Biochem Biophys 276:538–542
Young W (1992) Role of calcium in central nervous system injury. J Neurotrauma 9:S9-S25
Yue T-L, Lysko PG, Feuerstein G (1990) Production of platelet-activating factor from rat cerebellar granule cells in culture. J Neurochem 54: 1809–1811
Yue T-L, Gleason M, Gu J-L, Lysko PG, Hallenbeck J, Feuerstein G (1991a) Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositied turnover in neurohybrid NG108–15 cells: Studies with BN50739, a new PAF antagonist. J Pharmacol Exp Therap 257:374–381
Yue T-L, Gleason M, Hallenbeck J, Feuerstein G (1991b) Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells. Neuroscience 41:177–185
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Doucet, J.P., Bazan, N.G. (1993). A Neural Primary Genomic Response to the Lipid Mediator Platelet-Activating Factor. In: Massarelli, R., Horrocks, L.A., Kanfer, J.N., Löffelholz, K. (eds) Phospholipids and Signal Transmission. Nato ASI Series, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02922-0_32
Download citation
DOI: https://doi.org/10.1007/978-3-662-02922-0_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02924-4
Online ISBN: 978-3-662-02922-0
eBook Packages: Springer Book Archive